Drugs Information:
Neostigmine
Basic Information
|
||
ID | DDInter1279 | |
Drug Type | small molecule | |
Molecular Formula | C12H19N2O2 | |
Molecular Weight | 223.292 | |
CAS Number | 59-99-4 | |
Description | A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier. | |
ATC Classification | N07AA01 S01EB06 N07AA51 | |
IUPAC Name | 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium | |
InChI | ALWKGYPQUAPLQC-UHFFFAOYSA-N | |
Canonical SMILES | CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Compound KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Wikipedia ChEMBL ZINC |
Interactions with
Neostigmine
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|